According to FutureWise analysis, the Poultry Vaccines market in 2025 is US$2.35 billion, and is expected to reach US$4.16 billion by 2033 at a CAGR of 7.4%. The expansion of the poultry market is driven by several factors, including the increasing prevalence of poultry diseases, a growing demand for high-quality poultry products, and a greater adoption of advanced vaccination programs to maintain flock health. Additionally, technological advancements in vaccine development and supportive government initiatives are contributing to global market growth. Vaccines for poultry are widely used to prevent and control contagious diseases. Their use in poultry production aims to avoid or reduce the emergence of clinical diseases at the farm level, thereby increasing overall production. Vaccination programs vary depending on several local factors, such as the type of production, regional disease patterns, costs, and potential losses. The poultry industry generally manages these programs. The financial losses caused by major epidemic diseases such as avian influenza and Newcastle disease have been significant over the past decade for both commercial and public sectors. Therefore, vaccination should be part of national or regional poultry disease eradication programs, under the official supervision of public veterinary services.The poultry industry is an essential component of global agriculture. Each year, over 8 billion birds valued at more than $20 billion are produced in the United States, with broiler chickens making up the majority of the market. Commercially produced birds are susceptible to various environmental pathogens, making vaccination a crucial part of flock health management.

Currently, the accepted practice in the industry is active vaccination using live vaccines. Common vaccines for hens include those for Marek’s disease (MDV), Newcastle disease (NDV), infectious bronchitis virus (IBV), and infectious bursal disease virus (IBDV). Turkeys typically receive vaccinations for NDV and the hepatitis E virus (HEV). Additionally, molecular recombinants, which involve inserting genes for immunogenic proteins from infectious organisms into a living viral vector, are being explored for commercial application. Efforts are also underway to increase vaccine efficacy by using adjuvants, particularly cytokines.

FutureWise Market Research has released a report that provides an in-depth analysis of the Poultry Vaccines Market trends that shall affect the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=5483&type=requestsample

By Product

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

By Disease Type

• Infectious Bronchitis
• Avian Influenza
• Marek’s Disease
• Newcastle Disease
• Salmonella

By Application

• Breeder
• Broiler
• Layer

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Poultry Vaccines Market:

• Merck & Co. Inc.
• Zoetis
• Boehringer Ingelheim International GmbH
• Ceva
• Hester Biosciences Limited
• Anicon GmbH
• Ringpu Biology
• Elanco
• Phibro Animal Health Corporation
• Indovax
• Harbin Veterinary Research Institut

Recent developments by key players in the Poultry Vaccines Market:

Zoetis

• In early 2025, Zoetis Inc. received a conditional USDA license for its avian influenza (H5N2) vaccine, marking the first approved pathway for commercial HPAI immunization in U.S. poultry.

Boehringer Ingelheim International GmbH

• Boehringer Ingelheim introduced its VAXXITEK HVT+IBD+H5 trivalent vaccine in Egypt in February 2025, providing combined protection against Marek’s disease, Infectious Bursal Disease, and H5 avian influenza, utilizing COBRA technology for broad clade coverage.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=5483&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Poultry Vaccines Market By Product, By Disease Type, By Application and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com